Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety, PK, and PD of TD-0714 in Healthy Adult and Elderly Subjects
NCT02709928Phase 1Completed
- Sponsor
- Theravance Biopharma, Inc.
- Start
- Mar 2016
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in heart failure (HF) comparing TD-0714 with Placebo (2 arms). Primary endpoint: Number and severity of adverse events. Started Mar 2016; status: completed.
02
Drugs
TD-0714
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02709928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02709928.